According to GuruFocus Insider Data, these are the largest CEO sales during the past week: PepsiCo Inc. (PEP, Financial), Glaukos Corp. (GKOS, Financial), Blue Buffalo Pet Products Inc. (BUFF, Financial) and PGT Inc. (PGTI, Financial).
PepsiCo: CEO, NAB Albert P. Carey sold 170,003 shares
PepsiCo CEO, NAB Albert P. Carey sold 170,003 shares for $108.81 per share on July 12. Pepsico has a market cap of $158.25 billion; its shares were traded around $109.96 with a P/E ratio of 30.97 and P/S ratio of 2.59. The trailing 12-month dividend yield of Pepsico stocks is 2.61%. Pepsico's forward dividend yield is 2.74%. It had an annual average earnings growth of 5.40% over the past 10 years. GuruFocus rated Pepsico the business predictability rank of 2-star.
PepsiCo stock prices have increased over the past five years.
PepsiCo’s biggest competitor is Coca-Cola (KO, Financial). It also faces competition with smaller, local brands as well as companies like Kellogg (K, Financial) and Monster Beverage (MNST, Financial). The company stresses the importance of successful promotion of existing products and new products and the importance of the effectiveness of its advertising campaigns to keep up with its competitors.
GuruFocus has found one severe warning sign for Pepsico:
- Declining operating margin.
PepsiCo has experienced declining operating margin due to increased operating costs, unfavorable foreign exchange, higher commodity cost, and increased advertising and marketing expenses.
PepsiCo declared net sales of $15.4 billion and net income of $2.0 billion in its second-quarter results. This is compared with last year’s second-quarter results of net sales of $16.0 billion and net income of $2.0 billion.
CEO, ESSA Ramon Laguarta sold 17,221 shares for $108.27 per share on July 11. SVP and Controller Marie T. Gallagher sold 13,586 shares for $109.01 per share on July 11.
Glaukos: CEO Thomas William Burns sold 162,254 shares
Glaukos CEO Thomas William Burns sold 162,254 shares for $30.07 per share on July 13. Glaukos has a market cap of $1 billion; its shares were traded around $30.85 with a P/S ratio of 3.64.
Over the past year, Glaukos stock prices have increased by 6%.
Glaukos is focused on transforming the treatment of glaucoma, one of the world’s leading cause of blindness. The company pioneered Micro-Invasive Glaucoma surgery, or MIGS, and launched iStent, its first MIGS device, in July 2012.
GuruFocus has recognized two severe warnings for Glaukos:
- Sloan ratio of 43.35%.
- Inventory buildup.
Glaukos reported revenue of $23.1 million and net income of $897,000 in its first-quarter results compared with its 2015 first-quarter results of revenue of $14.7 million and net loss of $1.5 million.
Glaukos attributes the growth in revenue to increased use of iStent and increased customers. Gross margin has increased because of the company’s fixed manufacturing costs against increasing sales.
Burns sold 7,997 shares for $30 per share on June 20. The price of the stock has increased by 2.83% since. Treasurer, CFO and Secretary Richard L. Harrison sold 10,000 shares in June and July. Chief Commercial Officer Chris M. Calcaterra sold 45,464 shares for $28.46 per share on June 15.
Blue Buffalo Pet Products: CEO Kurt Schmidt sold 150,000 shares
Blue Buffalo Pet Products CEO Kurt Schmidt sold 150,000 shares for $21.29 per share on July 5. Blue Buffalo Pet Products has a market cap of $4.93 billion; its shares were traded around $25.11 with a P/E ratio of 66.07 and P/S ratio of 4.69.
Blue Buffalo Pet Products stock prices have declined slightly since the company first went public in July 2015.
GuruFocus has recognized one severe warning sign for Blue Buffalo Pet Products:
- Inventory buildup.
Blue Buffalo Pet Products declared net sales of $280 million, an increase of 12.5%, and net income of $37 million, an increase of 24.3%, in its first-quarter results. Blue Buffalo Pet Products attributes increased net sales primarily to volume growth.
Blue Buffalo Pet Products expects net sales and gross margin to continue to grow in the future. The company is still focused on making strategic initiatives and brand building for the rest of 2016.
PGT: Chairman and CEO Rodney Hershberger sold 100,000 shares
PGT Chairman and CEO Rodney Hershberger sold 100,000 shares for $11.24 per share on July 8. PGT has a market cap of $569.130 million; its shares were traded around $11.69 with a P/E ratio of 31.61 and P/S ratio of 1.50.
PGT stock prices have increased significantly over the past five years.
GuruFocus has not recognized any severe warning signs for PGT.
PGT reported net sales of $100.2 million and net income of $1.5 million in its first-quarter results. This is compared with last year’s first-quarter results of net sales of $95.3 million and net income of $6.7 million.
PGT net sales have increased as a result of the execution of its long term strategies and acquisitions. The company’s gross profit increased while its expenses declined. Net income increasing is attributed to higher profitability on the leverage from higher sales.
Start a free seven-day trial of Premium Membership to GuruFocus.
